Home > Research > Immunology > Vaccinology > African swine fever virus
Vaccinology staff are also working toward the development of a safe and effective ASFV vaccine. ASF is a highly contagious fatal acute haemorrhagic viral disease of pigs which causes major economic losses. ASFV is currently endemic in many sub-Saharan African countries and in Madagascar and Sardinia. There is no vaccine available and disease control relies on implementing movement restrictions and slaughter policies which are difficult to achieve in countries lacking a good infrastructure. To date, the use of empirical methods have failed to produce an effective vaccine, partly due to the complexity of the virus, the acute fatal nature of the disease and a poor understanding of the what types of immune response protect against infection. Recent studies have highlighted an important role for CD8+ T cells in immunity induced by a naturally occurring, avirulent isolate of ASFV. Consequently we are working on the development of a vaccine that induces an appropriate CD8+ T-cell response.
Our current ASFV studies are:
In these studies, we are collaborating with Linda Dixon?s group who is producing mutant ASFV.